Accessibility Menu
 
Bionik Laboratories logo

Bionik Laboratories

(OTC) BNKL

Current Price$0.00
Market CapN/A
Since IPO (2015)-100%
5 Year-100%
1 Year+0%
1 Month-99%

Bionik Laboratories Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$1.81M

Net Income (TTM)

$5.07M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

918.85 (High)

Price

$0.00

Volume

1

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

BNKL News

No articles available.

BNKL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bionik Laboratories

Industry

Healthcare Equipment and Supplies

Employees

13

CEO

Richard Russo, Jr., CPA

Headquarters

Watertown, MA 02472, US

BNKL Financials

Key Financial Metrics (TTM)

Gross Margin

55%

Operating Margin

-3%

Net Income Margin

-3%

Return on Equity

0%

Return on Capital

-5%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$0.00

Shares Outstanding

12.48M

Volume

1

Short Interest

0.00%

Avg. Volume

244.767

Financials (TTM)

Gross Profit

$989.88K

Operating Income

$4.83M

EBITDA

$4.78M

Operating Cash Flow

$3.39M

Capital Expenditure

$8.69K

Free Cash Flow

$3.39M

Cash & ST Invst.

$427.38K

Total Debt

$2.41M

Bionik Laboratories Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2023YOY CHG

Revenue

$501.11K

+162.0%

Gross Profit

$254.12K

+91.6%

Gross Margin

50.71%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

N/A

Employees

12

N/A

Net Income

$1.42M

+29.6%

EBITDA

$1.28M

+11.2%

Quarterly Fundamentals

Name
Q4 2023YOY CHG

Net Cash

$1.98M

-199.7%

Accounts Receivable

$453.08K

+64.9%

Inventory

$1.03M

-13.1%

Long Term Debt

$2.39M

N/A

Short Term Debt

$22.07K

N/A

Return on Assets

-1.47%

N/A

Return on Invested Capital

-4.58%

N/A

Free Cash Flow

$757.70K

+45.1%

Operating Cash Flow

$756.94K

+45.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BGMDBG Medicine, Inc.
$0.00+0.00%
OHAQOracle Healthcare Acquisition Corp.
$0.00+0.00%
FSPMFusionPharm, Inc.
$0.00+0.00%
BIMIBIMI International Medical Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CMCSAComcast
$29.02+0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
QQQInvesco QQQ Trust
$582.06-0.02%

Questions About BNKL

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.